Enavogliflozin
| CAS No. | 1415472-28-4 | Cat. No. | BCP48002 |
| Name | Enavogliflozin | ||
| Synonyms | DWP-16001; DWP 16001; DWP16001; | ||
| Formula | C24H27ClO6 | M. Wt | 446.92 |
| Description | Enavogliflozin, also known as DWP-16001, is an antidiabetic (hypoglycemic) agent. It is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor. DWP16001 is currently in a phase 2 clinical trial as a novel anti-diabetes drug for the treatment of type 2 diabetes by selective inhibition of sodium-glucose cotransporter 2. | ||
| Pathways | Ion Channel/Membrane Transporter GPCR/G Protein | ||
| Targets | SGLT | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.